SenesTech, Inc. (SNES)

In November 2025, SenesTech reported record revenue and adjusted EBITDA for Q3 2025, and the Belize Raptor Center became an official distributor of Evolve. In February 2026, the company reported significant reductions in rodent activity following Evolve deployments, received approval for Evolve in New Zealand, and announced it would directly manage Amazon sales of its Evolve products. In March 2026, SenesTech announced a 20% increase in revenue for 2025, driven by e-commerce growth, but missed analyst estimates for EPS and revenue. In May 2026, Michael Edell was appointed President and Chief Executive Officer. The stock experienced a decline of 12.53% from April 23, 2025, to April 22, 2026, with high volatility and substantial shareholder dilution. The company's market capitalization is less than US$10 million, and historically, the stock has moved lower after earnings reports.

Demand for SenesTech's rodent control products is influenced by seasonal trends in pest activity. Demand tends to increase in the fall and winter months as temperatures drop, prompting rodents to seek shelter indoors. The spring also marks a peak season, driven by agricultural cycles and increased gardening activities. Fluctuations in weather conditions, such as temperature and precipitation, can also impact rodent populations and, consequently, the demand for rodenticides.

SenesTech, Inc. is an agricultural biotechnology life-sciences company specializing in fertility management for animal pest control, focusing on humane, effective, and sustainable solutions, primarily for rat populations. Its major products include ContraPest, a contraceptive for male and female rats, and Evolve, a soft bait product line of minimum-risk contraceptives containing cottonseed oil.

SenesTech, Inc. is headquartered in Phoenix, Arizona, where it also has its manufacturing site, serving both the United States and international markets. Recent international expansion efforts include regulatory approval for Evolve in New Zealand and Australia, with stocking shipments anticipated in the second or third quarter of 2025. SenesTech also announced the Belize Raptor Center as an official distributor of Evolve in November 2025 and has a new distribution deal in India. The company's Evolve Rat Birth Control has seen successful urban deployments in locations such as Hong Kong and San Francisco. Domestically, SenesTech distributes its products through top pest management and agriculture distributors, e-commerce platforms like Amazon and Lowe's, brick-and-mortar retail, and city/government programs.

SenesTech has cultivated a reputation as an "Emerging Leader" in the North American rodenticides market, recognized for its innovative, eco-friendly rodenticides and integrated pest management solutions. Evolve has fueled revenue growth and margin expansion, with successful urban deployments demonstrating significant reductions in rodent activity. However, the company faces challenges due to its financial health, including unprofitability, negative margins, and an Altman Z-Score indicating a high possibility of bankruptcy. SenesTech also competes against larger, more established companies.

SenesTech, Inc. has a diverse ownership structure including institutional owners such as Sabby Management, LLC, and Renaissance Technologies LLC, who collectively hold 15.02% of the company's stock. Major individual owners, considered insiders, include Grover T. Wickersham, the largest individual shareholder, and Glenbrook Capital Management, with insiders collectively owning 82.94% of the company. Retail investors hold the remaining 2.03%.